Aptevo Therapeutics Inc.APVONASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank27
Studio
Year-over-Year Change

Price-to-earnings ratio

Percentile
P27
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthElevated
PeriodValueYoY Change
2024-0.05+61.2%
2023-0.13-108.6%
20221.47+213.7%
2021-1.30+81.5%
2020-7.00-
20190.00-
20180.00-
20170.00-
20160.00-
20150.00-